7

Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors

davidd submitted, created time 10 months 2 days (www.nature.com)

Multidrug resistance is often associated with the (over)expression of drug efflux transporters of the ATP-binding cassette (ABC) protein family. This minireview discusses the role of one selected ABC-transporter family member, the breast cancer resistance protein (BCRP/ABCG2), in the (pre)clinical efficacy of novel experimental anticancer drugs, in particular tyrosine kinase inhibitors.

 
davidd commented 10 months ago - Re: Drug transporters: recent advances concerning BCRP and t ...
0     
The article represents a new key substance, BRCD, to cancer cells. Thus, targeting BCRP in these tumour stem cells with potent and specific inhibitors might constitute an important strategy to eliminate or reduce the tumour stem cell population and improve the efficacy of targeted therapy.
NOTE: Please Sign in or Register first
Comment Subject      
Content
This comment is my hypotheses
 

About Us
DiscoveR8 is a user-driven website dedicated to the dissemination and intelligent discussion of life science news, discoveries, hypotheses, and procedures. Our users are our sources, editors, and peer reviewers.
More...
Report Abuse
abuse@discover8.com
pRNAT-H1.1/Adeno
siRNA Vector : pRNAT-H1.1/Adeno
www.genscript.com
Heparanase (HPA) 1, human
Recombinant heparanase protein HPA1 is produced in CHO cells ...
www.genscript.com
pRNATin-H1.4/Lenti
A synthetic peptide corresponding to residues 410 through 41 ...
www.genscript.com
Western Membrane Forceps
The Western Membrane Forceps are crafted from No. 304 stainl ...
www.genscript.com